Guijing Wang1, Zefeng Zhang2, Carma Ayala2, Diane O Dunet2, Jing Fang2, Mary G George2. 1. Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: Gbw9@cdc.gov. 2. Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
BACKGROUND: Estimates for the average cost of stroke have varied 20-fold in the United States. To provide a robust cost estimate, we conducted a comprehensive analysis of the hospitalization costs for stroke patients by diagnosis status and event type. METHODS: Using the 2006-2008 MarketScan inpatient database, we identified 97,374 hospitalizations with a primary or secondary diagnosis of stroke. We analyzed the costs after stratifying the hospitalizations by stroke type (hemorrhagic, ischemic, and other strokes) and diagnosis status (primary and secondary). We employed regressions to estimate the impact of event type and diagnosis status on costs while controlling for major potential confounders. RESULTS: Among the 97,374 hospitalizations (average cost: $20,396 ± $23,256), the number with ischemic, hemorrhagic, or other strokes was 62,637, 16,331, and 48,208, respectively, with these types having average costs, in turn, of $18,963 ± $21,454, $32,035 ± $32,046, and $19,248 ± $21,703. A majority (62%) of the hospitalizations had stroke listed as a secondary diagnosis only. Regression analysis found that, overall, hemorrhagic stroke cost $14,499 more than ischemic stroke (P < .001). For hospitalizations with a primary diagnosis of ischemic stroke, those with a secondary diagnosis of ischemic heart disease (IHD) had costs that were $9836 higher (P < .001) than those without IHD. CONCLUSIONS: The costs of hospitalizations involving stroke are high and vary greatly by type of stroke, diagnosis status, and comorbidities. These findings should be incorporated into cost-effective strategies to reduce the impact of stroke. Published by Elsevier Inc.
BACKGROUND: Estimates for the average cost of stroke have varied 20-fold in the United States. To provide a robust cost estimate, we conducted a comprehensive analysis of the hospitalization costs for strokepatients by diagnosis status and event type. METHODS: Using the 2006-2008 MarketScan inpatient database, we identified 97,374 hospitalizations with a primary or secondary diagnosis of stroke. We analyzed the costs after stratifying the hospitalizations by stroke type (hemorrhagic, ischemic, and other strokes) and diagnosis status (primary and secondary). We employed regressions to estimate the impact of event type and diagnosis status on costs while controlling for major potential confounders. RESULTS: Among the 97,374 hospitalizations (average cost: $20,396 ± $23,256), the number with ischemic, hemorrhagic, or other strokes was 62,637, 16,331, and 48,208, respectively, with these types having average costs, in turn, of $18,963 ± $21,454, $32,035 ± $32,046, and $19,248 ± $21,703. A majority (62%) of the hospitalizations had stroke listed as a secondary diagnosis only. Regression analysis found that, overall, hemorrhagic stroke cost $14,499 more than ischemic stroke (P < .001). For hospitalizations with a primary diagnosis of ischemic stroke, those with a secondary diagnosis of ischemic heart disease (IHD) had costs that were $9836 higher (P < .001) than those without IHD. CONCLUSIONS: The costs of hospitalizations involving stroke are high and vary greatly by type of stroke, diagnosis status, and comorbidities. These findings should be incorporated into cost-effective strategies to reduce the impact of stroke. Published by Elsevier Inc.
Entities:
Keywords:
Cost; comorbidity; diagnosis type; stroke type
Authors: Peter L Kolominsky-Rabas; Peter U Heuschmann; Daniela Marschall; Martin Emmert; Nikoline Baltzer; Bernhard Neundörfer; Oliver Schöffski; Karl J Krobot Journal: Stroke Date: 2006-03-30 Impact factor: 7.914
Authors: Felicitas J Detmer; Sara Hadad; Bong Jae Chung; Fernando Mut; Martin Slawski; Norman Juchler; Vartan Kurtcuoglu; Sven Hirsch; Philippe Bijlenga; Yuya Uchiyama; Soichiro Fujimura; Makoto Yamamoto; Yuichi Murayama; Hiroyuki Takao; Timo Koivisto; Juhana Frösen; Juan R Cebral Journal: Neurosurg Focus Date: 2019-07-01 Impact factor: 4.047
Authors: Felicitas J Detmer; Bong Jae Chung; Fernando Mut; Martin Slawski; Farid Hamzei-Sichani; Christopher Putman; Carlos Jiménez; Juan R Cebral Journal: Int J Comput Assist Radiol Surg Date: 2018-08-09 Impact factor: 2.924
Authors: Felicitas J Detmer; Daniel Lückehe; Fernando Mut; Martin Slawski; Sven Hirsch; Philippe Bijlenga; Gabriele von Voigt; Juan R Cebral Journal: Int J Comput Assist Radiol Surg Date: 2019-09-04 Impact factor: 2.924
Authors: Darian R Esfahani; Dilip Pandey; Xinjian Du; Linda Rose-Finnell; Fady T Charbel; Colin P Derdeyn; Sepideh Amin-Hanjani Journal: Stroke Date: 2018-08 Impact factor: 7.914
Authors: Brian Silver; Tariq Hamid; Muhib Khan; Mario Di Napoli; Reza Behrouz; Gustavo Saposnik; Jo-Ann Sarafin; Susan Martin; Majaz Moonis; Nils Henninger; Richard Goddeau; Adalia Jun-O'Connell; Shawna M Cutting; Ali Saad; Shadi Yaghi; Wiley Hall; Susanne Muehlschlegel; Raphael Carandang; Marcey Osgood; Bradford B Thompson; Corey R Fehnel; Linda C Wendell; N Stevenson Potter; James M Gilchrist; Bruce Barton Journal: J Neurol Sci Date: 2019-12-05 Impact factor: 3.181
Authors: Felicitas J Detmer; Daniel Fajardo-Jiménez; Fernando Mut; Norman Juchler; Sven Hirsch; Vitor Mendes Pereira; Philippe Bijlenga; Juan R Cebral Journal: Acta Neurochir (Wien) Date: 2018-10-30 Impact factor: 2.216